This inventor holds 1 USPTO granted patent and 3 published patent applications and 4 EPO patents. Top assignees: Assistance Publique-Hopitaux De Paris, Université Paris Descartes, Université Paris-Sud 11. Active years: 2013.
Company Filing History:
1 out of 331 
1 out of 132 
1 out of 43 Years Active: 2013
Title: Luc Mouthon: Innovator in Pulmonary Artery Hypertension Diagnosis
Introduction
Luc Mouthon is a notable inventor based in Saint Mandé, France. He has made significant contributions to the field of medical diagnostics, particularly in the detection of pulmonary artery hypertension (PAHT). His innovative approach has the potential to improve patient outcomes through early diagnosis.
Latest Patents
Luc Mouthon holds a patent for a method aimed at diagnosing pulmonary artery hypertension. This invention relates to an in vitro method for detecting PAHT or the risk of developing it. The method includes determining the presence and/or amount of anti-tenascin C antibodies in a biological sample from a patient. This breakthrough could lead to more effective monitoring and treatment strategies for individuals at risk.
Career Highlights
Throughout his career, Luc Mouthon has worked with prominent institutions such as Assistance Publique-Hôpitaux de Paris and Université Paris Descartes. His experience in these organizations has allowed him to collaborate with leading experts in the field, enhancing his research and innovation capabilities.
Collaborations
Luc has collaborated with esteemed colleagues, including Marc Humbert and Mathieu Tamby. These partnerships have contributed to the advancement of his research and the development of his patented methods.
Conclusion
Luc Mouthon's work in the field of pulmonary artery hypertension diagnosis exemplifies the impact of innovative thinking in medicine. His contributions are paving the way for improved diagnostic techniques that can significantly benefit patient care.